IPO success research is rooted in long-run underperformance and the underpricing puzzle, which is attributed to asymmetric information between informed and uninformed investors. Our purpose is to determine if hedge fund performance can explain long-run IPO success. We fill in two research gaps. First, our long-run study extends the recent research on the role of hedge funds in explaining short-run U.S. IPO success. Second, we address the scarcity in long-run IPO research by testing periods beyond 3-to-5 years. Our main IPO success measure is a function of net proceeds and post-IPO market prices. This measure, used in recent short-run IPO success research, has a different interpretation when applied to long-run tests. This is because long-run price performance replaces mispricing as the major consideration. We find that hedge funds perform well for periods over a year when long-run IPO success is poor. In contrast, stocks similar to IPO perform well when IPO success is better. The Vuong test shows that the hedge fund returns specification provides a better fit to the observed data than market returns. Long-run findings differ from short-run findings as market performance now exercises both an opposite and stronger association with IPO success compared to hedge fund performance.
No takes yet. Share an insight, caveat, or question.
Hull et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: